Ernexa Therapeutics Inc.

ERNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.91

-$0.05 (-1.26%)

Sep 22, 2026, 12:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	1.88M	1.73M	7.58M	11.45M	16.99M	1.63M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	59K	1M	-449K
Other Long-Term Assets	110K	118K	4.22M	5.23M	488K	453K
Receivables	95K	437K	425K	951K	684K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.15M	186K	1.6M	n/a	n/a	n/a
Total Current Assets	3.13M	2.35M	9.6M	13.68M	18.77M	1.73M
Property-Plant & Equipment	547K	755K	33.27M	1.27M	3.24M	2.69M
Goodwill & Intangibles	2.04M	2.04M	2.04M	2.04M	8.03M	8.03M
Total Long-Term Assets	2.7M	2.92M	39.53M	8.6M	12.76M	11.17M
Total Assets	5.83M	5.27M	49.13M	22.28M	31.53M	12.91M
Account Payables	1.13M	1.72M	1.07M	1.62M	1.76M	1.28M
Deferred Revenue	n/a	n/a	190K	n/a	n/a	76K
Short-Term Debt	213K	207K	n/a	1.75M	n/a	526K
Other Current Liabilities	1.76M	12K	109K	-322K	903K	681K
Total Current Liabilities	3.11M	2.94M	6.57M	7.65M	3.68M	3.13M
Long-Term Debt	n/a	n/a	6.77M	1.21M	n/a	194K
Other Long-Term Liabilities	43K	153K	307K	425K	47K	23K
Total Long-Term Liabilities	320K	630K	40.33M	2.52M	2.34M	2.12M
Total Liabilities	3.43M	3.57M	46.9M	10.17M	6.02M	5.25M
Total Debt	490K	684K	41.84M	4.14M	2.72M	2.9M
Book Value	2.4M	1.7M	2.23M	12.11M	25.5M	7.66M
Book Value Per Share	9.52	1.50	10.51	99.21	294.50	110.50
Common Stock	39K	257K	27K	26K	13K	25.8M
Retained Earnings	-245.64M	-231.54M	-186.98M	-165.3M	-140.7M	-18.14M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	245K
Shareholders Equity	2.4M	1.7M	2.23M	12.11M	25.5M	7.66M
Total Investments	n/a	n/a	n/a	59K	1M	-449K